This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global market for bone grafts and substitutes. Product segments covered by this report include allografts and synthetic bone substitutes, growth factors, and cellular bone matrices. Geographic segments covered include the US, five major European markets (France, Germany, Italy, Spain, and the UK), Japan, and the Rest of World. The forecast range for this report is 2019-25.
The combined global market for bone grafts and substitutes totaled approximately $1.9bn in 2020. Although sales were negatively impacted by the COVID-19 pandemic, the market rebounded in 2021 and is expected to continue to increase in value over the forecast period, returning to more normal levels of growth between 2022 and 2025.
Key drivers of the bone grafts market include the aging of the population and the global burden of musculoskeletal disease, along with rising procedure volumes for spinal fusion and joint replacement surgeries. Market limiters include the high price of premium products such as growth factors and cellular bone matrices, as well as a hesitance in certain countries to use human-based allograft tissue for bone grafting.
Also included in this report:
- a clinical overview of bone grafting and its current applications
- spinal fusion procedure volume forecasts by country/region
- osteoarthritis prevalence forecasts by country/region
